News
Cantor Fitzgerald Reiterates Overweight on Lyra Therapeutics
17 Apr 24
News, Reiteration, Analyst Ratings
B of A Securities Maintains Buy on Lyra Therapeutics, Lowers Price Target to $11
25 Mar 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Lyra Therapeutics, Maintains $12 Price Target
22 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Press releases
Thinking about buying stock in GameStop, Equinix, Lyra Therapeutics, Krystal Biotech, or KULR Technology?
26 Mar 24
Opinion, Press Releases
Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
21 Mar 24
Earnings, Press Releases
Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
1 Mar 24
Press Releases